CDCA5 and hepatocellular carcinoma: Owing to the fact that the alteration in CTNNB1 can result in the inhibited degradation of the encoded protein (β-catenin) and constitutive activation of β-catenin in HCC [15–17], this finding suggested that there was no association between the activation of Wnt signaling pathway and CDCA5 up-regulation.